Skip to main content
Erschienen in: Supportive Care in Cancer 7/2005

01.07.2005 | Original Article

Venting direct percutaneous jejunostomy (DPEJ) for drainage of malignant bowel obstruction in patients operated on for gastric cancer

verfasst von: Giuseppe Piccinni, Anna Angrisano, Mario Testini, Domenico Merlicco, Michele Nacchiero

Erschienen in: Supportive Care in Cancer | Ausgabe 7/2005

Einloggen, um Zugang zu erhalten

Abstract

Malignant chronic bowel obstruction (MCBO) is a syndrome caused by abdomen-pelvic diffusion of neoplastic diseases of any origin. It generally occurs in an advanced disease, affecting 3–15% of patients recently operated, untreated, or submitted to radiotherapy. Patients complain of chronic pain and vomitus. The approach to this problem is multidisciplinary, involving the surgeon, the endoscopist, the oncologist, and the pain-therapy expert. Direct percutaneous jejunostomy (DPEJ) using a percutaneous endoscopic gastrostomy (PEG) tube is a jejunal percutaneous access procedure indicated for nutrition in those patients whose stomach cannot be used, as in cases of partially or totally gastrectomized ones. A venting PEG or percutaneous endoscopic jejunostomy (PEJ) is a solution to drain the gastrointestinal tract for MCBO even in difficult cases represented by patients with previous abdominal surgery, those with partial or total gastrectomies, ascites, or peritoneal carcinosis. We report our five-case experience of draining an MCBO in patients previously operated on for gastric cancer, using a DPEJ technique that we believe is the best technique for this purpose.
Literatur
1.
Zurück zum Zitat Cannizzaro R, Bortoluzzi F, Valentini M, Scarabelli C, Campagnutta E, Sozzi M, Fornasarig M, Poletti M (1995 ) Percutaneous endoscopic gastrostomy as a decompressive technique in bowel obstruction due to abdominal carcinomatosis. Endoscopy 27:317–320 Cannizzaro R, Bortoluzzi F, Valentini M, Scarabelli C, Campagnutta E, Sozzi M, Fornasarig M, Poletti M (1995 ) Percutaneous endoscopic gastrostomy as a decompressive technique in bowel obstruction due to abdominal carcinomatosis. Endoscopy 27:317–320
2.
Zurück zum Zitat Gauderer MW (2002) Percutaneous endoscopic gastrostomy and the evolution of contemporary long-term enteral access. Clin Nutr 21:103–110 Gauderer MW (2002) Percutaneous endoscopic gastrostomy and the evolution of contemporary long-term enteral access. Clin Nutr 21:103–110
3.
Zurück zum Zitat Gorman CR, Morris JB (1997) Minimally invasive access to the gastrointestinal tract. In: Rombeau JL, Rolandelli RH (eds) Enteral and tube feeding, 3rd edn. Saunders, Philadelphia, pp. 189 Gorman CR, Morris JB (1997) Minimally invasive access to the gastrointestinal tract. In: Rombeau JL, Rolandelli RH (eds) Enteral and tube feeding, 3rd edn. Saunders, Philadelphia, pp. 189
4.
Zurück zum Zitat Hünerbein M (2004) Endoscopic and surgical palliation of gastrointestinal tumors. Support Care Cancer 12:155–160 Hünerbein M (2004) Endoscopic and surgical palliation of gastrointestinal tumors. Support Care Cancer 12:155–160
5.
Zurück zum Zitat Karpeh MS, Kelsen DP, Tepper JE (2001) Cancer of the stomach. In: De Vita Jr VT, Hellman S, Rosenberg SA (eds), Cancer principles and practices of oncology, 6th edn. Lippincott, Philadelphia, pp 1092–1126 Karpeh MS, Kelsen DP, Tepper JE (2001) Cancer of the stomach. In: De Vita Jr VT, Hellman S, Rosenberg SA (eds), Cancer principles and practices of oncology, 6th edn. Lippincott, Philadelphia, pp 1092–1126
6.
Zurück zum Zitat Lau PWK, Lorentz TG (1993) Results of surgery for malignant bowel obstruction in advanced, unresectable, recurrent colon cancer. Dis Colon Rectum 36:61–64PubMed Lau PWK, Lorentz TG (1993) Results of surgery for malignant bowel obstruction in advanced, unresectable, recurrent colon cancer. Dis Colon Rectum 36:61–64PubMed
7.
Zurück zum Zitat Piccinni G, Angrisano A,Testini M, Bonomo GM (2004) Definitive palliation for neoplastic colonic obstruction using enteral stents: personal case-series with literature review. World J Gastroenterol 10:758–764 Piccinni G, Angrisano A,Testini M, Bonomo GM (2004) Definitive palliation for neoplastic colonic obstruction using enteral stents: personal case-series with literature review. World J Gastroenterol 10:758–764
8.
Zurück zum Zitat Ripamonti C, Twycross R, Baines M, Bozzetti F, Capri S, De Conno F, Gemlo B, Hunt TM, Krebs HB, Mercadante S, Schaerer R, Wilkinson P (2001) Clinical practice recommendations for the management of bowel obstruction in patients with end-stage cancer. Support Care Cancer 9:223–233 Ripamonti C, Twycross R, Baines M, Bozzetti F, Capri S, De Conno F, Gemlo B, Hunt TM, Krebs HB, Mercadante S, Schaerer R, Wilkinson P (2001) Clinical practice recommendations for the management of bowel obstruction in patients with end-stage cancer. Support Care Cancer 9:223–233
9.
Zurück zum Zitat Scheidbach H, Horbach Th, Groitl H, Hohenberger W (1999) Percutaneous endoscopic gastrostomy/jejunostomy (PEG/PEJ) for decompression in the upper gastrointestinal tract. Surg Endosc 13:1103–1105 Scheidbach H, Horbach Th, Groitl H, Hohenberger W (1999) Percutaneous endoscopic gastrostomy/jejunostomy (PEG/PEJ) for decompression in the upper gastrointestinal tract. Surg Endosc 13:1103–1105
10.
Zurück zum Zitat Shike M, Schroy P, Ritchie MA, Lightdale CJ, Morse R (1987) Percutaneous endoscopic jejunostomy in cancer patients with previous gastric resection. Gastrointest Endosc 33:372–374 Shike M, Schroy P, Ritchie MA, Lightdale CJ, Morse R (1987) Percutaneous endoscopic jejunostomy in cancer patients with previous gastric resection. Gastrointest Endosc 33:372–374
11.
Zurück zum Zitat Shike M, Latkany L (1998) Direct percutaneous endoscopic jejunostomy. Gastrointest Endosc Clin N Am 8:569–580 Shike M, Latkany L (1998) Direct percutaneous endoscopic jejunostomy. Gastrointest Endosc Clin N Am 8:569–580
12.
Zurück zum Zitat Stellato TA, Gauderer MW (1987) Percutaneous endoscopic gastrostomy for gastrointestinal decompression. Ann Surg 205:119–122 Stellato TA, Gauderer MW (1987) Percutaneous endoscopic gastrostomy for gastrointestinal decompression. Ann Surg 205:119–122
13.
Zurück zum Zitat Stellato TA, Gauderer M W Ponsky J L (1984) Percutaneous endoscopic gastrostomy following previous abdominal surgery. Ann Surg 200:46–50 Stellato TA, Gauderer M W Ponsky J L (1984) Percutaneous endoscopic gastrostomy following previous abdominal surgery. Ann Surg 200:46–50
14.
Zurück zum Zitat Tapia J, Murguia R, Garcia G, Espinoza de los Monteros P, Oñate E (1999) Jejunostomy: techniques, indications and complications. World J Surg 23:596–602 Tapia J, Murguia R, Garcia G, Espinoza de los Monteros P, Oñate E (1999) Jejunostomy: techniques, indications and complications. World J Surg 23:596–602
15.
Zurück zum Zitat Vargo JJ, Germain MM, Swenson JA, Harrison CR (1993) Ultrasound–assisted percutaneous endoscopic gastrostomy in a patient with advanced ovarian carcinoma and recurrent intestinal obstruction. Am J Gastroenterol 88:1946–1948 Vargo JJ, Germain MM, Swenson JA, Harrison CR (1993) Ultrasound–assisted percutaneous endoscopic gastrostomy in a patient with advanced ovarian carcinoma and recurrent intestinal obstruction. Am J Gastroenterol 88:1946–1948
Metadaten
Titel
Venting direct percutaneous jejunostomy (DPEJ) for drainage of malignant bowel obstruction in patients operated on for gastric cancer
verfasst von
Giuseppe Piccinni
Anna Angrisano
Mario Testini
Domenico Merlicco
Michele Nacchiero
Publikationsdatum
01.07.2005
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 7/2005
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-004-0749-4

Weitere Artikel der Ausgabe 7/2005

Supportive Care in Cancer 7/2005 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.